Fountoulakis M - Search Results

1

Regulation of PCNA and CAF-1 expression by the two tuberous sclerosis gene products.

Hengstschläger M, Rosner M, Fountoulakis M, Lubec G. Hengstschläger M, et al. Among authors: fountoulakis m. Biochem Biophys Res Commun. 2003 Aug 1;307(3):737-42. doi: 10.1016/s0006-291x(03)01238-5. Biochem Biophys Res Commun. 2003. PMID: 12893285

2

Aberrant expression of centractin and capping proteins, integral constituents of the dynactin complex, in fetal down syndrome brain.

Gulesserian T, Kim SH, Fountoulakis M, Lubec G. Gulesserian T, et al. Among authors: fountoulakis m. Biochem Biophys Res Commun. 2002 Feb 15;291(1):62-7. doi: 10.1006/bbrc.2002.6389. Biochem Biophys Res Commun. 2002. PMID: 11829462

3

Reduction of actin-related protein complex 2/3 in fetal Down syndrome brain.

Weitzdoerfer R, Fountoulakis M, Lubec G. Weitzdoerfer R, et al. Among authors: fountoulakis m. Biochem Biophys Res Commun. 2002 May 3;293(2):836-41. doi: 10.1016/S0006-291X(02)00291-7. Biochem Biophys Res Commun. 2002. PMID: 12054546

4

Tuberous sclerosis genes regulate cellular 14-3-3 protein levels.

Hengstschläger M, Rosner M, Fountoulakis M, Lubec G. Hengstschläger M, et al. Among authors: fountoulakis m. Biochem Biophys Res Commun. 2003 Dec 19;312(3):676-83. doi: 10.1016/j.bbrc.2003.10.170. Biochem Biophys Res Commun. 2003. PMID: 14680818

5

Protein levels of alpha1-tubulin, protein disulfide isomerase, tropomyosins and vimentin are regulated by the tuberous sclerosis gene products.

Hengstschläger M, Rosner M, Fountoulakis M, Oh JE, Lubec G. Hengstschläger M, et al. Among authors: fountoulakis m. Cancer Lett. 2004 Jul 16;210(2):219-26. doi: 10.1016/j.canlet.2004.01.021. Cancer Lett. 2004. PMID: 15183538

6

The cellular response to ectopic overexpression of the tuberous sclerosis genes, TSC1 and TSC2: a proteomic approach.

Hengstschläger M, Rosner M, Fountoulakis M, Lubec G. Hengstschläger M, et al. Among authors: fountoulakis m. Int J Oncol. 2005 Sep;27(3):831-8. Int J Oncol. 2005. PMID: 16077935

7

Deranged expression of molecular chaperones in brains of patients with Alzheimer's disease.

Yoo BC, Kim SH, Cairns N, Fountoulakis M, Lubec G. Yoo BC, et al. Among authors: fountoulakis m. Biochem Biophys Res Commun. 2001 Jan 12;280(1):249-58. doi: 10.1006/bbrc.2000.4109. Biochem Biophys Res Commun. 2001. PMID: 11162507

8

Aberrant expression of signaling-related proteins 14-3-3 gamma and RACK1 in fetal Down syndrome brain (trisomy 21).

Peyrl A, Weitzdoerfer R, Gulesserian T, Fountoulakis M, Lubec G. Peyrl A, et al. Among authors: fountoulakis m. Electrophoresis. 2002 Jan;23(1):152-7. doi: 10.1002/1522-2683(200201)23:1<152::AID-ELPS152>3.0.CO;2-T. Electrophoresis. 2002. PMID: 11824616

9

Human brain nucleoside diphosphate kinase activity is decreased in Alzheimer's disease and Down syndrome.

Kim SH, Fountoulakis M, Cairns NJ, Lubec G. Kim SH, et al. Among authors: fountoulakis m. Biochem Biophys Res Commun. 2002 Aug 30;296(4):970-5. doi: 10.1016/s0006-291x(02)02035-1. Biochem Biophys Res Commun. 2002. PMID: 12200143

10

Reduced levels of DEAD-box proteins DBP-RB and p72 in fetal Down syndrome brains.

Kircher SG, Kim SH, Fountoulakis M, Lubec G. Kircher SG, et al. Among authors: fountoulakis m. Neurochem Res. 2002 Oct;27(10):1141-6. doi: 10.1023/a:1020921324871. Neurochem Res. 2002. PMID: 12462412

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

222 results

Search Page

Filters